Merck | MRK - Beneficio Bruto En Ventas

Precio De Mercado
107.40
Cambio Diario
-1.95 -1.78%
Mensual
-16.19%
Anual
-18.79%
Q1 Expectativa
104.71




Beneficio Bruto En Ventas Cambio Fecha
Adidas EUR 3.09B 347M 2025-12
Adyen EUR 1.08B 788.66M 2024-12
Akzo Nobel EUR 1.04B 10M 2025-06
Alcon AG USD 1.52B 58M 2025-12
Amadeus IT EUR 980.6M 246.8M 2025-12
Amarin USD 23.17M 961K 2025-12
AstraZeneca USD 12.39B 5M 2025-12
BASF EUR 3.11B 55M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Beiersdorf EUR 1.54B 1.16B 2025-06
Covestro EUR 488M 64M 2025-09
Danone EUR 6.82B 23M 2024-12
Fresenius EUR 1.51B 214M 2025-12
Fresenius Medical Care EUR 1.39B 147M 2025-12
Galapagos EUR -13.57M 74.82M 2025-09
Genmab DKK 868M 195M 2025-06
Givaudan CHF 823M 575M 2024-06
GlaxoSmithKline GBP 6.18B 106M 2025-12
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Infineon EUR 1.46B 42M 2025-12
Linde USD 4.24B 47M 2025-09
Lonza CHF 1.29B 248M 2025-06
Merck EUR 2.96B 252M 2025-12
Novartis USD 10.82B 695M 2025-09
Philips EUR 2.29B 377M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
UCB EUR 2.46B 520M 2024-12